Drug & Device Team provides recommendations based on Food & Drug Administration (FDA) draft guidance on Quality Management System ...
Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified ...
Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license ...
Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today reported its financial results ...
Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immun ...
4d
Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
Company reports $14.3 million in revenue in Q3'25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and collaboration revenue - - Reports positive feedback from the FDA ...
Fitbit may no longer be the only name in fitness trackers, but it remains one of the most reliable and approachable brands out there. The best Fitbit devices are an especially good option for anyone ...
Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback